CRO

WIL buys Ricerca's Lyon site; Sponsors, CROs still tinkering with partnering models;

> WIL Research has bought Ricerca Biosciences' pharmaceutical services hub in Lyon, France, adding to its European nonclinical safety assessment capabilities. Article

> Two Michigan CROs, PharmOptima and Ophthy-DS, have united to offer ocular R&D services to clients around the globe. More

> CRO Advance Research Associates has teamed up with clinical study management outfit MedNet Solutions for biostatistical work. News

> MicroConstants has expanded its biomarker testing services, adding capabilities in multiplex immunoassays, gene expression and profiling assays. Item

> Sponsors are putting more and more responsibility on their CRO partners, but no one has created a perfect model for risk-sharing, executives say. Story